NDAORALTABLET
Approved
Dec 2005
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
ADVIL PM (advil pm) by GSK is cyclooxygenase inhibitors [moa]. First approved in 2005.
Drug data last refreshed 11h ago · AI intelligence enriched Yesterday
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ADVIL PM is an oral tablet combination of ibuprofen (NSAID) and diphenhydramine (antihistamine) designed for nighttime pain relief and sleep support. It works via cyclooxygenase inhibition to reduce inflammation and pain while the antihistamine component promotes sleep. The product targets consumers seeking integrated pain and sleep solutions without prescription.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), signaling contraction phase requiring defensive portfolio strategies and potential team rightsizing.
Mechanism of Action
Cyclooxygenase Inhibitors
Pharmacologic Class:
Nonsteroidal Anti-inflammatory Drug
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on ADVIL PM offers limited long-term career growth given LOE approaching status and zero currently linked job openings; roles focus on defending market share and maximizing cash flow. This assignment is better suited for experienced professionals managing mature brands or those seeking stability rather than growth acceleration.
Brand Manager
Worked on ADVIL PM at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.